Clinical Trials Logo
  1. Home
  2. Rhabdomyolysis
  3. NCT06101680
  4. Details
NCT06101680 Clinical Trial

RhabdomYolyse in Intensive caRe

Rhabdomyolysis Clinical Trial

— RYR  

Official title:
RhabdomYolyse in Intensive caRe

Clinical Trial Details — Status: Active, not recruiting

Administrative data
NCT number NCT06101680
Other study ID # 2022PI201
Secondary ID
Status Active, not recruiting
Phase
First received
Last updated
Start date October 1, 2023
Est. completion date January 1, 2024

Study information
Verified date October 2023
Source Central Hospital, Nancy, France
Contact n/a
Is FDA regulated No
Health authority
Study type Observational

Clinical Trial Summary

Analysis of the outcome of patients < 18 years old, treated in an intensive care unit for severe rhabdomyolysis, regardless of etiology (renal failure rate, death rate, organ replacement rate)

Recruitment information / eligibility
Status Active, not recruiting
Enrollment 200
Est. completion date January 1, 2024
Est. primary completion date December 1, 2023
Accepts healthy volunteers No
Gender All
Age group 0 Years to 18 Years
Eligibility Inclusion Criteria: - CPK > 5000 UI/L - Care in Pediatric Intensive Care Unit - Age < 18 years old Exclusion Criteria: - Parental refusal

Study Design

Related Conditions & MeSH terms

Locations
Country Name City State
France Reanimation Pediatrique Nancy

Sponsors (1)
Lead Sponsor Collaborator
Central Hospital, Nancy, France

Country where clinical trial is conducted

France, 

Outcome
Type Measure Description Time frame Safety issue
Primary Use of renal remplacement therapy Use of renal remplacement therapy in case of severe rhabdomyolysis in children in intensive care unit 7 days after admission in intensive care unit
See also
  Status Clinical Trial Phase
Completed NCT03737513 - Exercise-induced Collective Rhabdomyolysis
Completed NCT00241748 - Pharmacoepidemiology and Pharmacogenetics of a Statin Adverse Event N/A
Not yet recruiting NCT02498366 - Exertional Rhabdomyolysis- Characterization of Prediction Tests for Return to Duty N/A
Not yet recruiting NCT06429982 - Dexamethasone Use in Pediatric Rhabdomyolysis Patients in Addition to Standard Protocols Phase 1
Withdrawn NCT02896517 - Support for the Rhabdomyolysis in an Emergency Department
Completed NCT01467180 - Myoglobin Removal by High Cut-off CVVHD N/A
Recruiting NCT01022450 - Study of the Causes of the Breakdown of Muscle Fibers in Hospitalized Patients N/A
Completed NCT00391911 - Study of N-Acetylcysteine (NAC) and Continuous Renal Replacement Therapy (CRRT) for the Treatment of Rhabdomyolysis Phase 2
Withdrawn NCT02111018 - Extracorporeal Therapy for the Removal of Myoglobin Using the CytoSorb in Patients With Rhabdomyolysis Phase 2
Completed NCT04913298 - Prospective Study for the Application of Cytosorb® in Critically Ill Patients N/A
Recruiting NCT05146336 - CytOSorb TreatMent Of Critically Ill PatientS Registry
Completed NCT03986736 - Markers of Tissue Injury and Rhabdomyolysis in Patients With Major Trauma
Not yet recruiting NCT02518724 - The Effect of Remote Ischemic Preconditioning on Physical Performance and Exertional Rhabdomyolysis N/A
Completed NCT02671604 - Rhabdomyolysis and Robot-assisted Radical Prostatectomy N/A
Completed NCT00592657 - Incidence of Rhabdomyolysis Among Patients Admitted With Jimsonweed Ingestions N/A
Completed NCT06338423 - Use of a Vacuum Mattress During Laparoscopic Sleeve Gastrectomy to Reduce the Concentration of Rhabdomyolysis Markers and Acute Renal Failure N/A
Completed NCT01976936 - Neuroprotection With Statin Therapy for Acute Recovery Trial Phase 2 Phase 2
Completed NCT04118608 - Rhabdomyolysis - a Study of Patient Characteristics and Laboratory Values to Guide Treatment
Completed NCT01544231 - Plasma Neutrophil Gelatinase Associated Lipocalin Levels During Emergency Management of Rhabdomyolysis N/A
Recruiting NCT00549029 - The Association of Genetic Polymorphisms With Statin-Induced Myopathy. N/A